Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
---|
01/06/2000 | CA2301024A1 Monoclonal antibody 3-6-a specific to surface of dendritic cells among the peripheral blood leukocytes |
01/05/2000 | EP0969092A1 Rice gene resistant to blast disease |
01/05/2000 | EP0969091A2 Leptin receptor gene-related protein |
01/05/2000 | EP0969018A1 Anti bacterial monoclonal antibodies |
01/05/2000 | EP0968723A1 Healing of wounds or fibrotic disorders using at least one agent against a growth factor |
01/05/2000 | EP0968648A1 Mammalian nonhuman transgenic animal having a constitutive or inducible expression of the human endonexin II gene or its muteins or its fragments |
01/05/2000 | EP0968291A2 Antibody fragment-polymer conjugates and humanized anti-il-8 monoclonal antibodies |
01/05/2000 | EP0968290A1 Anti-alphavbeta3 humanized monoclonal antibodies |
01/05/2000 | EP0968289A1 Icam-6 materials and methods |
01/05/2000 | EP0968288A1 A HUMAN 2-19 PROTEIN HOMOLOGUE, z219a |
01/05/2000 | EP0968286A1 Growth factor receptor binding protein |
01/05/2000 | EP0968285A1 Morphogenic proteins |
01/05/2000 | EP0968276A1 NOVEL clpL |
01/05/2000 | EP0968230A1 Oxidized fragments of apolipoprotein b and their use |
01/05/2000 | EP0968229A1 Antigenic peptides reacting with anti-ovary antibodies |
01/05/2000 | EP0968225A1 NOVEL spsB |
01/05/2000 | EP0968002A1 Concurrent in-vivo immunoconjugate binding to multiple epitopes of vascular permeability factor on tumor-associated blood vessels |
01/05/2000 | EP0967996A2 Use of preparations containing anti-cd44 antibodies in the treatment of certain tumours and the suppression of immune reactions |
01/05/2000 | EP0967995A1 Composition comprising immunoglobulin |
01/05/2000 | EP0967994A1 Improved method for treatment and diagnosis of il-5 mediated disorders |
01/05/2000 | EP0967993A2 Anti-cocaine vaccine |
01/05/2000 | EP0967992A1 Peptide vaccine to prevent development of several herpes virus infections and/or atherosclerotic plaque |
01/05/2000 | EP0967990A1 UDP-N-ACETYLMURAMOYL-L-AIANINE:D-GLUTAMATE LIGASE (murD) OF STAPHYLOCOCCUS AUREUS |
01/05/2000 | EP0967878A1 Targeted cytotoxic cells |
01/05/2000 | EP0859791A4 Methods for detection of cryptosporidium oocysts |
01/05/2000 | EP0851912A4 Novel factors which modify gene transcription and methods of use therefor |
01/05/2000 | EP0721469B1 Anti-gp39 antibodies and uses therefor |
01/05/2000 | DE19819476C1 Polypeptid mit immunogenen Eigenschaften und veränderten biologischen Funktionen eines Proteins Polypeptide having immunogenic properties and altered biological function of a protein |
01/04/2000 | US6011139 Polypeptides |
01/04/2000 | US6011138 Gamma-1 anti-human CD23 monoclonal antibodies |
01/04/2000 | US6011137 Fusion proteins |
01/04/2000 | US6011009 Method for determining angiogenesis using scatter factor |
01/04/2000 | US6011002 Circularly permuted ligands and circularly permuted chimeric molecules |
01/04/2000 | US6010913 Isolated human tau peptide |
01/04/2000 | US6010903 Anti-human ceruloplasmin monoclonal antibody |
01/04/2000 | US6010902 Complex useful in controlling lymphocytes |
01/04/2000 | US6010897 Expression of signal-peptide-free staphylokinases |
01/04/2000 | US6010886 Receptor for oncostatin M |
01/04/2000 | US6010884 Recombinant binding proteins and peptides |
01/04/2000 | US6010881 Useful to screen compounds for antibiotic activity. polynucleotides that encode ribg polypeptides |
01/04/2000 | US6010878 Interleukin-1 β converting enzyme like apoptotic protease-6 |
01/04/2000 | US6010877 cDNA clone HE8CS41 that encodes a novel 7-transmembrane receptor |
01/04/2000 | US6010874 Early onset alzheimer's disease gene and gene products |
01/04/2000 | US6010872 Recombinant production of TGF-β type III receptor (betaglycan) polypeptides |
01/04/2000 | US6010865 Process for detecting a variant CD44 gene product |
01/04/2000 | US6010864 Peptides representing epitopic sites on r-IFN-β,antibodies thereto, and uses thereof |
01/04/2000 | US6010862 Methods of detecting collagen type III degradation in vivo |
01/04/2000 | US6010861 Target specific screens and their use for discovering small organic molecular pharmacophores |
01/04/2000 | US6010855 Desaturase antigen of mycobacterium tuberculosis |
01/04/2000 | US6010845 Leukocyte adhesion assay |
01/04/2000 | US6010704 Polypeptides and antibodies characteristic of papillomavirus, and diagnostic procedures and vaccines making use of them |
01/04/2000 | US6010696 Enhancing hematopoietic progenitor cell engraftment using mesenchymal stem cells |
01/04/2000 | US6010680 Thiolation of proteins for radionuclide-based radioimmunodetection and radioimmunotherapy |
01/04/2000 | CA2045658C Polypeptides having a .beta.-adremergic receptor activity in humans, involved_in the lipolytic response, nucleic acids coding for these polypeptides and use of these polypeptides for the screening of active substances on these polypeptides |
01/04/2000 | CA1340869C T cell activation markers |
12/30/1999 | DE19828466A1 Suppressor peptides derived from antibodies for use in immunoassays |
12/30/1999 | DE19828377A1 A transgenic non-human mammal expressing immunoglobulin E heavy chain, useful for testing of anti-human IgE antibodies |
12/30/1999 | CA2244211A1 Novel compounds |
12/29/1999 | WO1999067415A1 Novel molecules of the t110-related protein family and uses thereof |
12/29/1999 | WO1999067391A1 Origin of replication and methods of use |
12/29/1999 | WO1999067384A2 Prostate cancer-associated genes |
12/29/1999 | WO1999067377A1 Human arf-related proteins |
12/29/1999 | WO1999067359A2 Bispecific antibodies for retargeting anticancer cytotoxic lymphocytes and hybriomas and monoclonal antibodies therefore |
12/29/1999 | WO1999067293A1 Peptide composition as immunogen for the treatment of allergy |
12/29/1999 | WO1999067285A1 Particles of hcv envelope proteins: use for vaccination |
12/29/1999 | WO1999067283A2 Two-kinase domain mitogen- and stress-activated protein kinases and uses thereof |
12/29/1999 | WO1999067282A2 Olfactory receptors and their uses |
12/29/1999 | WO1999067269A1 Nucleic acid molecule encoding an ankyrin repeat tvl-1 protein and methods of use thereof |
12/29/1999 | WO1999066957A2 Artificial t helper cell epitopes as immune stimulators for synthetic peptide immunogens |
12/29/1999 | WO1999066956A1 IMMUNOLOGICAL AGENTS SPECIFIC FOR PRION PROTEIN (PrP) |
12/29/1999 | WO1999066955A1 The process of preparing immunoglobulin for intravenous injection by viruses double-sterilized without adding any protectant |
12/29/1999 | WO1999066951A2 Use of bi-specific antibodies for pre-targeting diagnosis and therapy |
12/29/1999 | WO1999066950A1 Synthetic somatostatin immunogen for growth promotion in farm animals |
12/29/1999 | WO1999066944A1 Methods for identifying novel multimeric agents that modulate receptors |
12/29/1999 | WO1999060133A3 Human nucleic acid methylases |
12/29/1999 | WO1999058681A3 Transgenic plant cells expressing a recombinant plant e2f peptide |
12/29/1999 | WO1999058563A3 Moraxella catharralis proteins |
12/29/1999 | WO1999057140A3 Growth-associated protease inhibitor heavy chain precursor |
12/29/1999 | WO1998055150A8 Txu-7-pap immunotoxin and use thereof |
12/29/1999 | WO1997040147A8 Antigenically reactive regions of the hepatitis a virus polyprotein |
12/29/1999 | EP0967284A1 Phosphodiesterases |
12/29/1999 | EP0967278A2 Flowering regulating gene and its use |
12/29/1999 | EP0967277A2 Production of chimeric mouse-human antibodies with specificity to human tumor antigens |
12/29/1999 | EP0966971A1 Cerebral stroke/cerebral edema preventive or remedy containing il-8 binding inhibitor as active ingredient |
12/29/1999 | EP0966970A1 Antigen specific to meniere's disease and medical use thereof |
12/29/1999 | EP0966537A2 AN $i(EX VIVO) ANIMAL OR CHALLENGE MODEL AS METHOD TO MEASURE PROTECTIVE IMMUNITY DIRECTED AGAINST PARASITES AND VACCINES SHOWN TO BE PROTECTIVE IN SAID METHOD |
12/29/1999 | EP0966535A1 Epitopes of the protein pre-m/m of the dengue virus, synthetic peptides |
12/29/1999 | EP0966533A1 Activity dependent neurotrophic factor iii (adnf iii) |
12/29/1999 | EP0966532A1 Biological material for treating a mammal by antibody gene transfer and pharmaceutical composition containing same |
12/29/1999 | EP0966485A1 MUTATED NONACTIVATING IgG2 DOMAINS AND ANTI-CD3 ANTIBODIES INCORPORATING THE SAME |
12/29/1999 | EP0966484A1 Neurotactin and uses therefor |
12/29/1999 | EP0966302A1 Methods of therapeutic administration of anti-cd40l compounds |
12/29/1999 | EP0966300A1 Treatment of autoimmune diseases, including aids |
12/29/1999 | EP0966296A1 Conjugated peptides, immunological reagent containing same and use thereof for treatment of immunological disorders |
12/29/1999 | EP0822993B1 Diagnostic methods and gene therapy using reagents derived from the human metastasis suppressor gene kai1 |
12/29/1999 | EP0614372B1 Antiviral factor from cd8+ cells |
12/29/1999 | EP0556292B1 Hepatitis c virus asialoglycoproteins |
12/29/1999 | EP0437547B1 Monoclonal antibodies against receptor-induced binding sites on ligands binding to proteins of the cytoadhesin super family |
12/29/1999 | CN1240028A Assay for detection of antibodies against P53 |
12/29/1999 | CN1240000A Polypeptides encoded by human lipase-like gene, compositions and methods |